RALA and breast cancer: Notably, consistently with that of FOXD1 expression, it is in the early BC patients that RalA expression was still higher in the CTCs≥5 group (n = 27) than in the CTCs<5 group (n = 31), suggesting that RalA also played a role in CTC formation in the early BC patients (Fig. 4E).